Oral Tirzepatide Ads Could Conflict with Meta’s Ad Policy, Raise Other Legal Questions

In December, the attorneys general of 35 U.S. states and territories wrote a letter calling on Meta to address “the surge of misleading marketing for weight loss products on Meta’s platforms,” particularly for compounded GLP-1 products, which do not have Food and Drug Administration (FDA) approval. The attorneys general said ads that include inaccurate claims…